Coimmune

Manufacturer of cytokine agents for treating cancer

placeDurham, North Carolina, United States calendar_todayFounded 2019 groups47 employees language coimmune.com

Registered entities

Investor mix

4 investors on record; lead investors include Array.

Investor typeCountShare
Venture capital250%
Bank & private debt125%
Other / undisclosed125%
Coming soon